What’s so special about VISFO’s consulting approach?

Published on
April 30, 2025
Contributors
Charlie Brook
Commercial Director

That depends on what you’re looking for.

If your team thrives on traditional consulting: milestone meetings, structured deliverables, and a clearly defined path - there’s absolutely nothing wrong with that. For many situations, that approach still works well.

But if your team moves quickly, works cross-functionally, and needs fast access to insight and alignment, our way of working might feel like a better fit.

At VISFO, we’ve shaped our consulting approach to support teams who are already smart, focused, and strategic, but want clearer answers and faster momentum. It’s a way of working that combines deep experience with real-time collaboration and sharp decision-making support. Nothing flashy, just thoughtful design to match how modern pharma teams actually operate.

Let’s walk through how it works.

We bring expertise that is relevant and ready

Many consultancies have skilled people. But our clients often tell us that what makes our team different is how quickly we add value.

We do not start from scratch. Our consultants have supported everything from early asset evaluations and Market Access planning to full launch execution. They’ve worked inside pharmaceutical companies, launched drugs into challenging markets, and sat across the table from payers. This experience means we understand the realities you face, and we know how to navigate them.

We come prepared, and we adapt quickly. Rather than working from a static playbook, we bring lived experience and proven thinking, shaped to fit your situation. It helps us ask better questions, challenge assumptions constructively, and make faster progress.

We do not aim to replace your team. We aim to act as an extension of it. Our work is about adding momentum and clarity to what you are already doing.

We integrate intelligence from the very beginning

Data can be powerful, but only when it is relevant, timely, and placed in the right context.

That is why we do not treat intelligence as an afterthought. Our consulting process starts with data. We use our proprietary platform, HelixAI, to access and organize real-world evidence, scientific publications, stakeholder activity, pricing benchmarks, and more. We filter and summarise what matters, based on your goals.

This approach does more than save time. It allows our consultants to come to discussions with a clear, shared understanding of the landscape. We already know what your competitors are doing. We already know what the evidence says. That foundation allows us to focus together on what to do next.

Rather than asking you for background, we bring it. That is what makes strategy sessions with us feel productive from day one.

We use structure to bring focus, not friction

We believe in strategic frameworks, but not templates. Strategy should have shape, not constraints.

Over time, we’ve developed a suite of frameworks that support everything from indication assessments and pricing decisions to stakeholder engagement and value communication. These frameworks help us keep projects clear, focused, and moving. They allow us to guide conversations and answer difficult questions without losing flexibility.

We adapt our approach to the challenge at hand. Our goal is not to push clients into a process. It is to help teams stay focused on the outcomes that matter.

When there is structure, it is easier to collaborate. It is easier to align with stakeholders. And it is much easier to spot when something needs to change.

We deliver in a way that fits how you work

Many consulting projects still rely on milestone calls, document drops, and waiting for feedback. That is not how most pharmaceutical teams operate anymore.

Our consulting is delivered through a collaborative platform. It allows us to keep everything in one place: from draft strategies and working documents to shared intelligence and real-time feedback.

This means we are not waiting for meetings to make progress. It also means that when something shifts, we can respond immediately.

We know that plans evolve. Priorities change. New data comes in. With our way of working, your strategy is always connected to the most current thinking. Because we are shaping it with you in real time.

We build strategy that keeps moving

In pharmaceutical development, no decision stands still. A strategy that was clear last month may need refinement today.

That is why our approach is built for continuous improvement. We do not hand over a report and walk away. We stay close to the work, helping you make new choices as the landscape shifts.

Because we start with precise intelligence and stay connected through our delivery model, we are able to adapt quickly. If a regulatory update lands or a competitor launches a new trial, we can factor that in immediately. If a payer signals a new preference, we help you adjust your messaging.

This agility is essential in a world where access, evidence, and influence are all evolving in real time.

Final thought

There are many effective ways to deliver consulting. Ours is designed for teams who want insight, clarity, and the ability to move forward without delay.

We believe in working alongside our clients, not above them. We believe the best strategy is shaped through collaboration. And we believe that the right combination of expert thinking, relevant evidence, and shared momentum leads to better decisions.

For many teams, that means we are not just a consultancy. We are a trusted part of the process.

If that sounds like the kind of support you have been looking for, we would love to start a conversation.